Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
about
Safety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitusChallenges and opportunities in achieving bioequivalence for fixed-dose combination products.Sitagliptin/metformin fixed-dose combination: in patients with type 2 diabetes mellitus.Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trials.Combination therapy of dipeptidyl peptidase-4 inhibitors and metformin in type 2 diabetes: rationale and evidence.Sitagliptin: a review of its use in patients with type 2 diabetes mellitus.Sitagliptin for Type 2 diabetes: a 2015 update.Population pharmacokinetic modeling and noncompartmental analysis demonstrated bioequivalence between metformin component of metformin/vildagliptin fixed-dose combination products and metformin immediate-release tablet sourced from various countriesSafety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated Review
P2860
Q27027877-876466B9-9AF5-4C97-86FB-DEB54B7F7C30Q36065586-D3EE1A3E-ADFD-4EE4-A9DA-FCFD5509A4FFQ37841554-DFE58C66-2932-46F4-9C13-800FFB834C90Q37870930-318C8CFA-E190-4E8E-BA88-8E4ACF52BB4EQ38106411-7A932474-9503-4DDF-90C9-C47715347D43Q38177173-14CB4E83-54BD-4FFA-A24F-053A72501ADEQ38497683-85E87E16-71D0-419D-8946-0BA6568A0F44Q39817871-CED6BCF2-C17B-48F4-953C-58F2D6166C71Q41097938-21C9ED73-BFAB-45A9-A6C0-C889ADFAE3C8
P2860
Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Bioequivalence of sitagliptin/ ...... , open-label, crossover study.
@en
Bioequivalence of sitagliptin/ ...... , open-label, crossover study.
@nl
type
label
Bioequivalence of sitagliptin/ ...... , open-label, crossover study.
@en
Bioequivalence of sitagliptin/ ...... , open-label, crossover study.
@nl
prefLabel
Bioequivalence of sitagliptin/ ...... , open-label, crossover study.
@en
Bioequivalence of sitagliptin/ ...... , open-label, crossover study.
@nl
P2093
P2860
P356
P1476
Bioequivalence of sitagliptin/ ...... , open-label, crossover study.
@en
P2093
Amy O Johnson-Levonas
Catherine Z Matthews
Elizabeth M Migoya
John A Wagner
Jutta L Miller
Keith M Gottesdiener
Maria Gutierrez
P2860
P304
P356
10.1007/BF03256914
P577
2010-01-01T00:00:00Z